Preserving Clinical Trial Integrity during the Coronavirus Pandemic

Mary M. McDermott; Anne B. Newman

doi:10.1001/jama.2020.4689

Preserving Clinical Trial Integrity during the Coronavirus Pandemic

Mary M. McDermott^*, Anne B. Newman

^*Corresponding author for this work

Medicine, General Medicine Division

Research output: Contribution to journal › Article › peer-review

138 Scopus citations

Original language	English (US)
Pages (from-to)	2135-2136
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	323
Issue number	21
DOIs	https://doi.org/10.1001/jama.2020.4689
State	Published - Jun 2 2020

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.2020.4689

Cite this

@article{e319656bcf4241cda4b5b405ff4da94f,

title = "Preserving Clinical Trial Integrity during the Coronavirus Pandemic",

author = "McDermott, {Mary M.} and Newman, {Anne B.}",

note = "Funding Information: reported receiving grants from the National Heart, Lung, and Blood Institute, National Institute on Aging, American Heart Association, and Regeneron; financial support for intervention for clinical trials from Helixmith, Hershey, Chromadex, ArtAssist, and ReserveAge; and nonfinancial support from Mars Inc. Dr Newman reported no disclosures.",

year = "2020",

month = jun,

day = "2",

doi = "10.1001/jama.2020.4689",

language = "English (US)",

volume = "323",

pages = "2135--2136",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "21",

}

TY - JOUR

T1 - Preserving Clinical Trial Integrity during the Coronavirus Pandemic

AU - McDermott, Mary M.

AU - Newman, Anne B.

N1 - Funding Information: reported receiving grants from the National Heart, Lung, and Blood Institute, National Institute on Aging, American Heart Association, and Regeneron; financial support for intervention for clinical trials from Helixmith, Hershey, Chromadex, ArtAssist, and ReserveAge; and nonfinancial support from Mars Inc. Dr Newman reported no disclosures.

PY - 2020/6/2

Y1 - 2020/6/2

UR - http://www.scopus.com/inward/record.url?scp=85082528685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082528685&partnerID=8YFLogxK

U2 - 10.1001/jama.2020.4689

DO - 10.1001/jama.2020.4689

M3 - Article

C2 - 32211830

AN - SCOPUS:85082528685

SN - 0098-7484

VL - 323

SP - 2135

EP - 2136

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 21

ER -

Preserving Clinical Trial Integrity during the Coronavirus Pandemic

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this